Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine in Elderly AML
NCT00373529Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2006
- Primary completion
- May 2008
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Sanofi. Started Oct 2006; status: completed.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00373529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373529.